First Therapeutic Approval for Eosinophilic Esophagitis

Rami A. Al‐Horani, Raquel Chiles
ISSN / E-ISSN
— / —
DOI
10.3390/gastroent13030024 ↗
Volume · Issue · Pages
13 · 3 · 238-244
Publisher
Multidisciplinary Digital Publishing Institute (MDPI)
Article URL
https://doi.org/10.3390/gastroent13030024 ↗
Article details
Unverified
Publication date (each date has its type and source)
30 Jul 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date30 Jul 2022 OpenAlex

Keywords (as given): eosinophilic esophagitis; dupilumab; FDA approval; biologic therapy; elimination diet; endoscopic dilation

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for 2022–23.
Journal
Gastroenterology Insights
Publication date used
30 Jul 2022 (OpenAlex publication date)
Applicable HEC period
2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
Category
Y
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2022-23 row 37431
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.